Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Akeso begins first-in-human study of AK-120 for atopic dermatitis

July 2, 2020

Amniox begins first phase III trial of TTAX-01 in diabetic foot ulcers

July 1, 2020

Ilumya approved in Japan for plaque psoriasis

July 1, 2020

FDA approves IND for SFA-002 study in psoriasis

July 1, 2020

AOBiome begins phase IIb study with B-244 for pruritus in atopic dermatitis

June 30, 2020

Boehringer Ingelheim identifies new pantetheinase inhibitors

June 29, 2020

Positive phase I/IIa results presented for AIV-001 in dermal scarring

June 29, 2020

Patient genetic variants linked to wound microbiomes

June 26, 2020

Reistone begins dosing in phase II study of SHR-0302 for alopecia areata

June 19, 2020

TOPADUR Pharma presents dual PDE5A inhibitors/soluble guanylate cyclase activators

June 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...